Mergers & Acquisitions Mergers & Acquisitions

Comment: Aon's EU remedy offer for Willis deal won't please everyone

By Andrew Boyce
  • 16 Apr 2021 10:36
  • 16 Apr 2021 10:43
Aon’s remedy offer to address EU concerns over its bid for Willis Towers Watson involves a significant but complex mix of businesses across Europe. But it might struggle to pacify regulators, given its lack of multinational reach and the EU's past approaches to deals that would leave just two major players

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Andrew Boyce

Correspondent


Andrew is a reporter covering merger reviews and competition policy for MLex in Brussels. He joined MLex in 2015 and holds a degree and a master’s degree in history from the University of Liverpool.

Discover MLex

Stay on top of global regulatory developments

Latest News